CERTIFICATION OF ENROLLMENT

SUBSTITUTE HOUSE BILL 3201



61st Legislature
2010 1st Special Session

Passed by the House April 2, 2010
  Yeas 53   Nays 37


________________________________________    
Speaker of the House of Representatives


Passed by the Senate March 18, 2010
  Yeas 26   Nays 17



________________________________________    
President of the Senate
CERTIFICATE

I, Barbara Baker, Chief Clerk of the House of Representatives of the State of Washington, do hereby certify that the attached is SUBSTITUTE HOUSE BILL 3201 as passed by the House of Representatives and the Senate on the dates hereon set forth.



________________________________________    
Chief Clerk
Approved 









________________________________________    
Governor of the State of Washington
FILED







Secretary of State
State of Washington


_____________________________________________ 

SUBSTITUTE HOUSE BILL 3201
_____________________________________________

AS AMENDED BY THE SENATE

Passed Legislature - 2010 1st Special Session
State of Washington61st Legislature2010 Regular Session

By House Ways & Means (originally sponsored by Representatives Pettigrew, Linville, Sullivan, and Ericks)

READ FIRST TIME 03/09/10.   



     AN ACT Relating to fees for treatment services and outreach for children with heritable disorders; and amending RCW 70.83.023.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:

Sec. 1   RCW 70.83.023 and 2007 c 259 s 8 are each amended to read as follows:
     The department has the authority to collect a fee of ((three)) eight dollars and ((fifty)) forty cents from the parents or other responsible party of each infant screened for congenital disorders as defined by the state board of health under RCW 70.83.020 to fund specialty clinics that provide treatment services for those with the defined disorders. The fee may also be used to support organizations conducting community outreach, education, and adult support related to sickle cell disease. The fee may be collected through the facility where a screening specimen is obtained.

--- END ---